Efficacy and Safety of Calculus Bovis Sativus (CBS) for Intracerebral Hemorrhage(CBSinICH)

NANot yet recruitingINTERVENTIONAL

Enrollment

300

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

March 1, 2026

Study Completion Date

January 1, 2027

Conditions

Intracerebral HemorrhageBrain Hemorrhage

Interventions

DRUG

Calculus bovis sativus (CBS)

Subjects will orally receive 300mg CBS per day from day 1 to day 7

DRUG

Natural Calculus Bovis(NCB)

Subjects will orally receive 300mg NCB per day from day 1 to day 7

Trial Locations (1)

Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei 430000, Hubei

All Listed Sponsors

collaborator

Jianmin Pharmaceutical Group Co., LTD.

INDUSTRY

lead

Tongji Hospital

OTHER

NCT07080632 - Efficacy and Safety of Calculus Bovis Sativus (CBS) for Intracerebral Hemorrhage(CBSinICH) | Biotech Hunter | Biotech Hunter